TradingKey

More Details of IDEXX Laboratories Inc Company

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Company Info

Ticker SymbolIDXX

Company nameIDEXX Laboratories Inc

IPO dateJun 21, 1991

CEOMr. Andrew Emerson

Number of employees11000

Security typeOrdinary Share

Fiscal year-endJun 21

AddressOne Idexx Drive

CityWESTBROOK

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code04092-2041

Phone12075560300

Websitehttps://www.idexx.com/

Ticker SymbolIDXX

IPO dateJun 21, 1991

CEOMr. Andrew Emerson

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

Name

Name/Position

Position

Shareholding

Change

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

Other

-662.63M

-66.37%

By RegionUSD

Name

Revenue

Proportion

United States

654.86M

65.59%

Europe & Middle East & Africa (EMEA) (Region)

204.55M

20.49%

Asia Pacific

81.73M

8.19%

Canada

37.30M

3.74%

Latin America

19.99M

2.00%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

Other

-662.63M

-66.37%

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

Other

70.25%

Shareholders

Proportion

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

Other

70.25%

Shareholder Types

Shareholders

Proportion

Investment Advisor

54.31%

Investment Advisor/Hedge Fund

32.80%

Research Firm

3.95%

Pension Fund

2.29%

Bank and Trust

2.06%

Hedge Fund

0.93%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.54%

Other

1.83%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

9.82M

12.21%

+146.37K

+1.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

5.44M

6.76%

+113.70K

+2.14%

Mar 31, 2025

State Street Global Advisors (US)

3.65M

4.54%

+12.32K

+0.34%

Mar 31, 2025

Fundsmith LLP

2.65M

3.29%

-14.52K

-0.55%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.41M

3%

+112.62K

+4.90%

Mar 31, 2025

Baron Capital Management, Inc.

2.06M

2.56%

+54.26K

+2.71%

Mar 31, 2025

Invesco Capital Management (QQQ Trust)

1.66M

2.07%

-25.31K

-1.50%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.4%

+414.80K

+58.32%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

1.09M

1.36%

-14.24K

-1.29%

Mar 31, 2025

Related ETFs

Updated: Sat, Sep 6

Name

Proportion

ProShares Pet Care ETF

10.39%

First Trust Water ETF

5.65%

iShares U.S. Medical Devices ETF

5.62%

Nuveen ESG Mid-Cap Growth ETF

3.56%

Simplify Next Intangible Core Index ETF

3.22%

Hennessy Sustainable ETF

3.19%

Adaptive Core ETF

2.75%

Janus Henderson Mid Cap Growth Alpha ETF

2.63%

Invesco Raymond James SB-1 Equity ETF

2.52%

First Trust S&P 500 Economic Moat Index ETF

2.42%

ProShares Pet Care ETF

Proportion10.39%

First Trust Water ETF

Proportion5.65%

iShares U.S. Medical Devices ETF

Proportion5.62%

Nuveen ESG Mid-Cap Growth ETF

Proportion3.56%

Simplify Next Intangible Core Index ETF

Proportion3.22%

Hennessy Sustainable ETF

Proportion3.19%

Adaptive Core ETF

Proportion2.75%

Janus Henderson Mid Cap Growth Alpha ETF

Proportion2.63%

Invesco Raymond James SB-1 Equity ETF

Proportion2.52%

First Trust S&P 500 Economic Moat Index ETF

Proportion2.42%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

IDEXX Laboratories Inc

643.990USD

IDEXX Laboratories Inc

643.990

Overview

Company

Financials

Analysis